Respiratory Function and Sleep Disordered Breathing in Pediatric Duchenne Muscular Dystrophy.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
20 09 2022
Historique:
received: 01 10 2021
accepted: 19 05 2022
pubmed: 12 8 2022
medline: 14 10 2022
entrez: 11 8 2022
Statut: ppublish

Résumé

The decline of respiratory function in Duchenne muscular dystrophy (DMD) is associated with sleep disordered breathing (SDB) and alteration of nocturnal gas exchange, first manifesting as nocturnal hypoventilation (NH). However, the correlation between the pulmonary function measured by spirometry (PFT) and the onset of SDB with or without NH is unclear. The aims of this study are to identify the prevalence and features of SDB and to investigate the relationship between lung function determined by forced vital capacity (FVC) and sleep abnormalities in a large pediatric DMD population. This was a retrospective, single-center cohort study. FVC% predicted (FVC%) was calculated using predicted equations from the Global Lung Function Initiative. NH was defined by transcutaneous (tc) CO2 >50 mm Hg for >25% of total sleep time (TST), borderline NH by a mean tcCO2 between 45 and 50 mm Hg or tcCO2>50 mm Hg for ≤25% of TST, and clinically meaningful obstructive sleep apnea (OSA) by obstructive apnea-hypopnea index >5. The sensitivity, specificity, and positive and negative predictive values of FVC < 50% to indicate the presence of nocturnal hypoventilation were calculated. One hundred thirty-four patients underwent 284 sleep studies and 1222 PFT. The mean (SD) age at the first and the last sleep study was 12.9 (2.7) and 14.3 (2.6) years, respectively. Borderline NH (n = 31) was detected in both ambulant and early-nonambulant participants, while 100% of NH cases (n = 14) were nonambulant. NH was detected in 4 of the 14 patients despite an FVC >50%. Seventeen of the 26 patients with OSA presented with concomitant NH or borderline NH. FVC <50% was associated with NH indicating a sensitivity and specificity of 73% and 86%, respectively. Positive and negative predictive values were 32% and 97%, respectively. PFT showed a nonlinear, sudden FVC% decline in 18% of cases. FVC% <50 was associated with NH in close to a third of patients. CO2 elevation can be associated with obstructive/pseudo-obstructive events and was also observed in early nonambulant cases or in the presence of FVC >50%. These results are relevant for the clinical management of SDB.

Sections du résumé

BACKGROUND AND OBJECTIVES
The decline of respiratory function in Duchenne muscular dystrophy (DMD) is associated with sleep disordered breathing (SDB) and alteration of nocturnal gas exchange, first manifesting as nocturnal hypoventilation (NH). However, the correlation between the pulmonary function measured by spirometry (PFT) and the onset of SDB with or without NH is unclear. The aims of this study are to identify the prevalence and features of SDB and to investigate the relationship between lung function determined by forced vital capacity (FVC) and sleep abnormalities in a large pediatric DMD population.
METHODS
This was a retrospective, single-center cohort study. FVC% predicted (FVC%) was calculated using predicted equations from the Global Lung Function Initiative. NH was defined by transcutaneous (tc) CO2 >50 mm Hg for >25% of total sleep time (TST), borderline NH by a mean tcCO2 between 45 and 50 mm Hg or tcCO2>50 mm Hg for ≤25% of TST, and clinically meaningful obstructive sleep apnea (OSA) by obstructive apnea-hypopnea index >5. The sensitivity, specificity, and positive and negative predictive values of FVC < 50% to indicate the presence of nocturnal hypoventilation were calculated.
RESULTS
One hundred thirty-four patients underwent 284 sleep studies and 1222 PFT. The mean (SD) age at the first and the last sleep study was 12.9 (2.7) and 14.3 (2.6) years, respectively. Borderline NH (n = 31) was detected in both ambulant and early-nonambulant participants, while 100% of NH cases (n = 14) were nonambulant. NH was detected in 4 of the 14 patients despite an FVC >50%. Seventeen of the 26 patients with OSA presented with concomitant NH or borderline NH. FVC <50% was associated with NH indicating a sensitivity and specificity of 73% and 86%, respectively. Positive and negative predictive values were 32% and 97%, respectively. PFT showed a nonlinear, sudden FVC% decline in 18% of cases.
DISCUSSION
FVC% <50 was associated with NH in close to a third of patients. CO2 elevation can be associated with obstructive/pseudo-obstructive events and was also observed in early nonambulant cases or in the presence of FVC >50%. These results are relevant for the clinical management of SDB.

Identifiants

pubmed: 35953292
pii: WNL.0000000000200932
doi: 10.1212/WNL.0000000000200932
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1216-e1226

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 American Academy of Neurology.

Auteurs

Alberto A Zambon (AA)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Federica Trucco (F)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Aidan Laverty (A)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Mollie Riley (M)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Deborah Ridout (D)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Adnan Y Manzur (AY)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Francois Abel (F)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Francesco Muntoni (F)

From the Dubowitz Neuromuscular Centre (A.A.Z., F.T., A.Y.M., F.M.), UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital, London, United Kingdom; Neuromuscular Repair Unit (A.A.Z.), Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; Children's Sleep Medicine (F.T., F.A.), Evelina Children Hospital-Paediatric Respiratory Department Royal Brompton Hospital, Guy's and St Thomas' Trust; Department of Paediatric Respiratory Medicine (A.L., M.R.), Great Ormond Street Hospital & UCL Institute of Child Health; NIHR Great Ormond Street Hospital Biomedical Research Centre (D.R., A.Y.M., F.M.); and Population (D.R.), Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom. f.muntoni@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH